• Connect with us
  • Information
    • About Us
    • Contact Us
    • Careers
    • Partnerships
    • Advertise With Us
    • Authors
    • Browse Topics
    • Events
    • Disclaimer
    • Privacy Policy
  • NORTH AMERICA EDITION
    Australia
    North America
    World
Login
Investing News NetworkYour trusted source for investing success
  • NORTH AMERICA EDITION
    North America
    Australia
    World
  • My INN
Videos
Companies
Press Releases
Private Placements
SUBSCRIBE
  • Reports & Guides
    • Market Outlook Reports
    • Investing Guides
  • Button
Resource
  • Precious Metals
  • Battery Metals
  • Base Metals
  • Energy
  • Critical Minerals
Tech
Life Science
Biotech Market
Biotech News
Biotech Stocks
  • Biotech Market
  • Biotech News
  • Biotech Stocks

Nasdaq Biotechnology Index Falls

Morag Mcgreevey
Sep. 28, 2015 10:35AM PST
Biotech Investing

U.S. stocks were down today, with biotechnology companies extending the previous week’s selloff.

U.S. stocks were down today, with biotechnology companies extending the previous week’s selloff.
According to Bloomberg:

The Nasdaq Biotechnology Index sank 4.5 percent after its worst week since 2011. Freeport-McMoRan Inc. tumbled 12 percent as copper dropped to the lowest in a month amid evidence of industrial weakness in China. Halliburton Co. and Marathon Oil Corp. lost at least 4.7 percent as oil prices slid. Amazon.com Inc. and Facebook Inc. fell more than 3.8 percent as investors sold some of the year’s better performers. Alcoa Inc. rose 2.4 percent after saying it will split into two publicly traded companies.
The Standard & Poor’s 500 Index fell 2 percent to 1,893.76 at 12:24 p.m. in New York, its lowest in a month. The Dow Jones Industrial Average lost 241.41 points, or 1.5 percent, to 16,073.26. The Nasdaq Composite Index dropped 2.2 percent.
“We are in a chaotic market, lots of volatility but not making much progress in either direction,” said James Gaul, a portfolio manager at Boston Advisors LLC, which oversees $2.8 billion. “Earnings are going to be really important this quarter considering the macro backdrop and general global fears as well as the concerns about the Fed potentially raising interest rates as early as next month.”

Click here to read the full article.

 

biotechnology-companies china dow-jones
The Conversation (0)

Go Deeper

AI Powered
Trading room with red financial data screens and traders at computer desks.

Tariff Shock: Trillions Wiped Out as Trade War Fears Spark Selloff

Gold bars on a financial chart background.

Gold Price, Markets Trade Flat After US Strikes on Iran

Latest News

Seegnal Expands Deployment of Seegnal's Prescription Intelligence Platform at Tel Aviv Sourasky Medical Center, a Leading Israeli Public Medical Center and Global Referral Center

More News

Outlook Reports

Resource
  • Precious Metals
    • Gold
    • Silver
  • Battery Metals
    • Lithium
    • Cobalt
    • Graphite
    • Electric Vehicles
  • Agriculture
  • Base Metals
    • Copper
    • Nickel
    • Zinc
  • Critical Metals
    • Rare Earths
  • Energy
    • Uranium
    • Oil and Gas
Tech
    • Artificial Intelligence
    • Cybersecurity
    • Robotics
    • Crypto
    • Cleantech
Life Science
    • Biotech
    • Cannabis
    • Pharmaceuticals

Featured Biotech Investing Stocks

More featured stocks

Browse Companies

Resource
  • Precious Metals
  • Battery Metals
  • Energy
  • Base Metals
  • Critical Metals
Tech
Life Science
MARKETS
COMMODITIES
CURRENCIES